Federated Hermes’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Federated Hermes’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,000	Closed	-$29.9K	–	2299
2022 Q4	$29.9K	Hold	4,000	–	–	﹤0.01%	1768
2022 Q3	$42K	Hold	4,000	–	–	﹤0.01%	1695
2022 Q2	$53K	Hold	4,000	–	–	﹤0.01%	1672
2022 Q1	$67K	Buy	4,000 +1,333	+50%	+$24.7K	﹤0.01%	1703
2021 Q4	$79K	Buy	2,667 +667	+33%	+$27.2K	﹤0.01%	1741
2021 Q3	$103K	Buy	2,000 +1,200	+150%	+$85.3K	﹤0.01%	1771
2021 Q2	$98K	Sell	800 -533	-40%	-$82.9K	﹤0.01%	1797
2021 Q1	$246K	Hold	1,333	–	–	﹤0.01%	1675
2020 Q4	$365K	Hold	1,333	–	–	﹤0.01%	1601
2020 Q3	$312K	Buy	+1,333	New	+$334K	﹤0.01%	1588

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

Federated Hermes's FRLN Position: Q1 2023 in Review

Federated Hermes sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2023, closing a stake of 4,000 shares — an estimated $29.9K sold.

Federated Hermes first reported a position in FRLN in Q3 2020 and held it in 10 quarters. The position peaked at $365K in Q4 2020. 15 funds tracked by Wall St. Rank hold FRLN as of Q1 2023.

Federated Hermes reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Federated Hermes sold 4,000 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2023, an estimated $29.9K.
Federated Hermes first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 10 quarters.
Federated Hermes's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $365K in Q4 2020.
15 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.